Company / Working Capital per Share
Marker Therapeutics, Inc. Working Capital per Share History
FY2018-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.65
FY2021
5-year range
$0.65 / $5.58
FY2018-FY2021
Trend
-31.9%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $5.58 to $0.65 over the past 3 years.
Based on SEC 10-K filings.
0.65 in FY2021.
Declined from $5.58 to $0.65 over the past 3 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -51.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, working capital per share decreased 31.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $0.65 | -31.9% |
| FY2019 | $0.96 | -82.8% |
| FY2018 | $5.58 | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026